Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
|
3.8B CNY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.8B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.6B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.1B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.1B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Henan Taloph Pharmaceutical Stock Co Ltd
Glance View
Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the pharmaceutical manufacturing industry. The company is headquartered in Zhengzhou, Henan and currently employs 2,209 full-time employees. The firm provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The firm's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The firm distributes its products mainly within domestic market.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Henan Taloph Pharmaceutical Stock Co Ltd is 5.5%, which is above its 3-year median of 4%.
Over the last 3 years, Henan Taloph Pharmaceutical Stock Co Ltd’s Operating Margin has increased from 2% to 5.5%. During this period, it reached a low of -2% on Jun 30, 2023 and a high of 8.6% on Jun 30, 2024.
